IL1B and infection: However, in different infection models, e.g., in SARS-CoV 2 infection, microbial components that, in the first phase, reduced the expression and production of IL-1 and IL-18, interfering with inflammasome-activation mechanisms, in the later stages of infection, activated the same mechanisms enhancing inflammasome responses [42].